Leukemia & Lymphoma, Volume 44, Issue 7 (2003)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 44, Issue 7 (2003)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Volume 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Research Article

Article
Caspase-mediated Cell Death in Hematological Malignancies: Theoretical Considerations, Methods of Assessment, and Clinical Implications
Piotr Smolewski, Zbigniew Darzynkiewicz & Tadeusz Robak
Pages: 1089-1104
Published online: 03 Aug 2009
AbstractforCaspase-mediated Cell Death in Hematological Malignancies: Theoretical Considerations, Methods of Assessment, and Clinical Implications | References | PDF (288.5 KB)
  • 30 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Role of IMP-SELECTIVE 5′-NUCLEOTIDASE (cN-II) in HEMATOLOGICAL MALIGNANCIES
Carlos M. Galmarini, Lars Jordheim & Charles Dumontet
Pages: 1105-1111
Published online: 03 Aug 2009
AbstractforRole of IMP-SELECTIVE 5′-NUCLEOTIDASE (cN-II) in HEMATOLOGICAL MALIGNANCIES | References | PDF (150.9 KB)
  • 112 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
Hepatitis C Virus (HCV) and Lymphomagenesis
Wen-Kai Weng & Shoshana Levy
Pages: 1113-1120
Published online: 03 Aug 2009
AbstractforHepatitis C Virus (HCV) and Lymphomagenesis | References | PDF (136.5 KB)
  • 115 Views
  • 72 CrossRef citations
  • 0Altmetric
Article
The Occurrence of Philadelphia Chromosome (Ph) Negative Leukemia after Hematopoietic Stem Cell Transplantation for Ph Positive Chronic Myeloid Leukemia: Implications for Disease Monitoring and Treatment
W.Y. Au, S.K. Ma & Y.L. Kwong
Pages: 1121-1129
Published online: 03 Aug 2009
AbstractforThe Occurrence of Philadelphia Chromosome (Ph) Negative Leukemia after Hematopoietic Stem Cell Transplantation for Ph Positive Chronic Myeloid Leukemia: Implications for Disease Monitoring and Treatment | References | PDF (203.1 KB)
  • 49 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Estrogen-regulated Conditional Oncoproteins: Tools to Address Open Questions in Normal Myeloid Cell Function, Normal Myeloid Differentiation, and the Genetic Basis of Differentiation Arrest in Myeloid Leukemia
David B. Sykes & Mark P. Kamps
Pages: 1131-1139
Published online: 03 Aug 2009
AbstractforEstrogen-regulated Conditional Oncoproteins: Tools to Address Open Questions in Normal Myeloid Cell Function, Normal Myeloid Differentiation, and the Genetic Basis of Differentiation Arrest in Myeloid Leukemia | References | PDF (211.4 KB)
  • 192 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Evaluation of Thalidomide for Treatment or Prevention of Chronic Graft-versus-host Disease
Mary E.D. Flowers & Paul J. Martin
Pages: 1141-1146
Published online: 03 Aug 2009
AbstractforEvaluation of Thalidomide for Treatment or Prevention of Chronic Graft-versus-host Disease | References | PDF (130.5 KB)
  • 63 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Intermediate Dose Thalidomide (200 mg Daily) has Comparable Efficacy and Less Toxicity than Higher Doses in Relapsed Multiple Myeloma
A.D. Wechalekar, C.I. Chen, D. Sutton, D. Reece, M. Voralia & A.K. Stewart
Pages: 1147-1149
Published online: 03 Aug 2009
AbstractforIntermediate Dose Thalidomide (200 mg Daily) has Comparable Efficacy and Less Toxicity than Higher Doses in Relapsed Multiple Myeloma | References | PDF (62.9 KB)
  • 47 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
BEAC or BEAM for High-dose Therapy in Patients with Non-Hodgkin's Lymphoma? A Single Centre Analysis on Toxicity and Efficacy
E. Jantunen, T. Kuittinen & T. Nousiainen
Pages: 1151-1158
Published online: 03 Aug 2009
AbstractforBEAC or BEAM for High-dose Therapy in Patients with Non-Hodgkin's Lymphoma? A Single Centre Analysis on Toxicity and Efficacy | References | PDF (141.4 KB)
  • 210 Views
  • 31 CrossRef citations
  • 0Altmetric
Article
Clinical Features and Outcome in HCV-positive Aggressive Non-Hodgkin's Lymphoma
Naoto Tomita, Fumio Kodama, Maki Takabayashi, Tomoko Kawano, Satoshi Yamaji, Katsumichi Fujimaki, Shin Fujisawa, Heiwa Kanamori, Shigeki Motomura & Yoshiaki Ishigatsubo
Pages: 1159-1164
Published online: 03 Aug 2009
AbstractforClinical Features and Outcome in HCV-positive Aggressive Non-Hodgkin's Lymphoma | References | PDF (179.1 KB)
  • 46 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)
Francis J. Giles, Carole B. Miller, David D. Hurd, John R. Wingard, Thomas R. Fleming, Stephen T. Sonis, Williamson Z. Bradford, Janis G. Pulliam, Elias J. Anaissie, Roy A. Beveridge, Mark M. Brunvand, Paul J. Martin & PROMPT-CT Trial Investigators†
Pages: 1165-1172
Published online: 03 Aug 2009
AbstractforA Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial) | References | PDF (144.7 KB)
  • 128 Views
  • 49 CrossRef citations
  • 0Altmetric
Article
Primary Breast Lymphoma
D. Gholam, F. Bibeau, A. El Weshi, J. Bosq & V. Ribrag
Pages: 1173-1178
Published online: 03 Aug 2009
AbstractforPrimary Breast Lymphoma | References | PDF (88.6 KB)
  • 252 Views
  • 84 CrossRef citations
  • 0Altmetric
Article
Mutant Type Glutathione S-transferase Theta 1 Gene Homologue to mTOR in Myelodysplastic Syndrome: Possible Clinical Application of Rapamycin
Yasuhiro Maeda, Terufumi Yamaguchi, Satomi Ueda, Koki Matsuo, Yasuyoshi Morita, Yoshito Naiki, Hajime Miyazato, Takahiro Shimada, Jun-ichi Miyatake, Mitsuhiro Matsuda & Akihisa Kanamaru
Pages: 1179-1185
Published online: 03 Aug 2009
AbstractforMutant Type Glutathione S-transferase Theta 1 Gene Homologue to mTOR in Myelodysplastic Syndrome: Possible Clinical Application of Rapamycin | References | PDF (273.6 KB)
  • 43 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Transcriptional Profiling During the Early Differentiation of Granulocyte and Monocyte Progenitors Controlled by Conditional Versions of the E2a–Pbx1 Oncoprotein
David B. Sykes, Jurgen Scheele, Martina Pasillas & Mark P. Kamps
Pages: 1187-1199
Published online: 03 Aug 2009
AbstractforTranscriptional Profiling During the Early Differentiation of Granulocyte and Monocyte Progenitors Controlled by Conditional Versions of the E2a–Pbx1 Oncoprotein | References | PDF (270.9 KB)
  • 230 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
In vitro Priming of Myeloma Antigen-specific Allogeneic Donor T Cells with Idiotype Pulsed Dendritic Cells
Sung-Bae Kim, Sivasubramanian Baskar & Larry W. Kwak
Pages: 1201-1208
Published online: 03 Aug 2009
AbstractforIn vitro Priming of Myeloma Antigen-specific Allogeneic Donor T Cells with Idiotype Pulsed Dendritic Cells | References | PDF (357.2 KB)
  • 47 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma
Quan Chen, Subrata Ray, Mohamad A. Hussein, Gordan Srkalovic & Alexandru Almasan
Pages: 1209-1214
Published online: 03 Aug 2009
AbstractforRole of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma | References | PDF (132.2 KB)
  • 44 Views
  • 29 CrossRef citations
  • 0Altmetric
Article
Infectious Mononucleosis Progressing to Fatal Malignant Lymphoma: A Case Report and Review of the Literature
C. Kobbervig, D. Norback & B. Kahl
Pages: 1215-1221
Published online: 03 Aug 2009
AbstractforInfectious Mononucleosis Progressing to Fatal Malignant Lymphoma: A Case Report and Review of the Literature | References | PDF (501.5 KB)
  • 73 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
A Case of Clinical Indolent Natural Killer Cell Lineage Large Granular Lymphocytic Leukemia in a Patient with Rheumatoid Arthritis
J.N. Machatschek, D. Westerman, H.M. Prince & J.F. Seymour
Pages: 1223-1227
Published online: 03 Aug 2009
AbstractforA Case of Clinical Indolent Natural Killer Cell Lineage Large Granular Lymphocytic Leukemia in a Patient with Rheumatoid Arthritis | References | PDF (148.4 KB)
  • 60 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Molecular Cytogenetic Approach to the Diagnosis of Splenic Lymphoma: A Case Report of Blastoid Mantle Cell Lymphoma
Erik Björck, Ola Landgren, Jacqueline Schoumans, Birger Christensson, Magnus Björkholm, Anna Porwit MacDonald & Magnus Nordenskjöld
Pages: 1229-1234
Published online: 03 Aug 2009
AbstractforMolecular Cytogenetic Approach to the Diagnosis of Splenic Lymphoma: A Case Report of Blastoid Mantle Cell Lymphoma | References | PDF (209.8 KB)
  • 48 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Involvement of Central Nervous System in Prolymphocytoid Transformation of Chronic Lymphocytic Leukemia
Hideyuki Kuwabara, Heiwa Kanamori, Hirotaka Takasaki, Maki Takabayashi, Satoshi Yamaji, Naoto Tomita, Katsumichi Fujimaki, Shin Fujisawa & Yoshiaki Ishigatsubo
Pages: 1235-1237
Published online: 03 Aug 2009
AbstractforInvolvement of Central Nervous System in Prolymphocytoid Transformation of Chronic Lymphocytic Leukemia | References | PDF (76.9 KB)
  • 86 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
Monica Pou, Nuria Saval, Manel Vera, Anna Saurina, Manel Solé, Francisco Cervantes & Albert Botey
Pages: 1239-1241
Published online: 03 Aug 2009
AbstractforAcute Renal Failure Secondary to Imatinib Mesylate Treatment in Chronic Myeloid Leukemia | References | PDF (89.6 KB)
  • 252 Views
  • 57 CrossRef citations
  • 0Altmetric
Article
Primary CD30/Ki-1 Positive Anaplastic Large Cell Lymphoma of the Central Nervous System Occurring in a Patient with a Seventeen-Year History of Essential Thrombocythemia
Yasutaka Tajima, Yusei Miyazaki, Takuya Higashi, Ri-ichiro Kishimoto, Kazumasa Sudoh, Akihisa Matsumoto, Seiji Kikuchi & Kunio Tashiro
Pages: 1243-1245
Published online: 03 Aug 2009
AbstractforPrimary CD30/Ki-1 Positive Anaplastic Large Cell Lymphoma of the Central Nervous System Occurring in a Patient with a Seventeen-Year History of Essential Thrombocythemia | References | PDF (129.3 KB)
  • 52 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Atypical Hemophagocytic Lymphohistiocytosis Following Bacterial Tonsillitis in Acute Lymphoblastic Leukemia
Toshio Kakihara, Chihaya Imai, Takayuki Kaneko, Atsushi Tanaka & Makoto Uchiyama
Pages: 1247-1248
Published online: 03 Aug 2009
AbstractforAtypical Hemophagocytic Lymphohistiocytosis Following Bacterial Tonsillitis in Acute Lymphoblastic Leukemia | References | PDF (54.3 KB)
  • 56 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Hepatitis B Virus Reactivation During Fludarabine Therapy in Non-Hodgkin's Lymphoma
Sinan Yavuz, Semra Paydas, Umut Disel & Berksoy Sahin
Pages: 1249-1250
Published online: 03 Aug 2009
CitationforHepatitis B Virus Reactivation During Fludarabine Therapy in Non-Hodgkin's Lymphoma | References | PDF (49.5 KB)
  • 33 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Complete Remission of Third Recurrence of Acute Myeloid Leukemia after Treatment with Imatinib (STI-571)
M. Schittenhelm, O. Aichele, S.M. Kröber, T. Brümmendorf, L. Kanz & C. Denzlinger
Pages: 1251-1253
Published online: 03 Aug 2009
AbstractforComplete Remission of Third Recurrence of Acute Myeloid Leukemia after Treatment with Imatinib (STI-571) | References | PDF (198.8 KB)
  • 34 Views
  • 12 CrossRef citations
  • 0Altmetric

Letter to Editor

Letter
Quantitative Evaluation of CD52 Expression in B-Cell Chronic Lymphocytic Leukemia
Giovanni D'Arena, Maria Luigia Vigliotti, Rosella Matera, Clelia Musto, Giovanni Iodice, Alfredo Tartarone & Nicola Di Renzo
Pages: 1255-1257
Published online: 03 Aug 2009
First Page PreviewforQuantitative Evaluation of CD52 Expression in B-Cell Chronic Lymphocytic Leukemia | References | PDF (62.8 KB)
  • 46 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Primary Gastric Lymphoma for Stage I/II1 E: Operative and Conservative Management in Retrospective Data from 71 Cases
Maria Luigia Vigliotti, Matteo Dell'Olio, Gianpiero Romano, Alfredo Tartarone, Giovanni D'Arena, Angelo Michele Carella & Nicola Di Renzo
Pages: 1259-1261
Published online: 03 Aug 2009
First Page PreviewforPrimary Gastric Lymphoma for Stage I/II1 E: Operative and Conservative Management in Retrospective Data from 71 Cases | References | PDF (103.1 KB)
  • 12 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Improvement of B-Cell Chronic Lymphocytic Leukemia During Haemodialysis: Possible Role for Endogenous Production of Factors Involved in Angiogenesis and Apoptosis?
Giovanni D'Arena, Vito Valente, Maria Luigia Vigliotti, Giovanni Plastino, Alfredo Tartarone, Giovanni Iodice, Clelia Musto, Rosella Matera & Nicola Di Renzo
Pages: 1263-1265
Published online: 03 Aug 2009
First Page PreviewforImprovement of B-Cell Chronic Lymphocytic Leukemia During Haemodialysis: Possible Role for Endogenous Production of Factors Involved in Angiogenesis and Apoptosis? | References | PDF (108.1 KB)
  • 13 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles